Medikine Initiates First Clinical Trial of its Lead Program, an Interleukin-7 Mimetic, Under Management Team with Expertise in Next-Generation Cytokine Drug Discovery and Development  https://t.co/dHZKKueVQF  https://t.co/Ik839Ii8OB